ClearPoint Neuro, Inc. (CLPT) vs Tactile Systems Technology, Inc. (TCMD)

ClearPoint Neuro, Inc. and Tactile Systems Technology, Inc. are both Medical Devices companies. Tactile Systems Technology, Inc. is the larger, with a market value of $518.5M against $445.7M — 1.2× the size. ClearPoint Neuro, Inc. has negative trailing earnings, so its P/E is not meaningful; Tactile Systems Technology, Inc. trades at 20.7×. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 17.2%. Tactile Systems Technology, Inc. has the higher net margin (7.10% vs −81.8%) and the higher return on invested capital (15.7% vs −61.3%). Across the 18 metrics below, Tactile Systems Technology, Inc. leads on 15 and ClearPoint Neuro, Inc. on 3.

Valuation

Metric CLPT TCMD Medical Devices median
P/E n/m 20.66 22.18
P/S 10.58 1.47 2.70
P/B 41.52 2.30 2.46
Price to free cash flow n/m 19.33 22.53
EV/EBITDA n/m 10.84 11.78
EV/Sales 11.08 1.29 2.38
Earnings yield (7.96%) 4.84% (8.22%)
Free cash flow yield (7.12%) 5.17% (7.80%)

Profitability

Metric CLPT TCMD Medical Devices median
Gross margin 62.61% 76.78% 56.01%
Operating margin (73.42%) 10.00% (15.03%)
Net margin (81.76%) 7.10% (20.40%)
Free cash flow margin (74.01%) 7.61% (7.24%)
Return on equity (226.52%) 11.88% (15.32%)
Return on assets (46.21%) 9.00% (19.72%)
Return on invested capital (61.31%) 15.74% (10.33%)

Growth

Metric CLPT TCMD Medical Devices median
Revenue growth (TTM) 25.86% 17.22% 8.80%
EPS growth (last fiscal year) (28.57%) 17.14% —
Revenue growth, 5-year CAGR 23.58% 11.98% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLPT TCMD Medical Devices median
Debt to equity 4.66 0.00 0.07
Current ratio 4.74 4.12 2.50
Net debt to EBITDA (0.14) (2.76) 0.49

Dividend

Metric CLPT TCMD Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CLPT TCMD Medical Devices median
Market cap 445.67m 518.51m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack